investors. However, the underwriter is required to purchase those shares at a later date, resulting in higher demand when share price is below initial public offering price. In contrary, higher number of
shares of NINE, at the price of not lower than Baht 2.62 per share. This is the average price of the NINE’s ordinary shares received by the Company, as appeared in No. 6, Expected benefits to the Company
, the information provided in this MD&A may vary if any factors or situation are changed in the future; the investors are, therefore, required to have their own discretion regarding the usage of this
% 17.4 % (1.9%) 16.7% 19.7% 3.0% Number of branches as at Dec 31 32 38 19% 32 38 19% 2018 2019 Change +/(-) Change +/(-) Q4/18 Q4/19 Operating highlight in Q4/2019 Revenue • After You Public Company
than CPO price at the time of delivery. As a result, the difference in raw material prices to the sales price at the date of manufacture and delivery of product to decrease. The Company possible to
last year which incurred at Baht 124.66 million, decrease by Baht 55.92 million or 37.14% as compared to the 1st quarter of 2022 ended as of march 31,2022 which incurred the realized net profit of Baht
Baht 199.66 million or 178.43 % as compared to the same period of last year which incurred at Baht 111.90 million, decrease by Baht 182.42 million or 192.71% as compared to the 2nd quarter of 2022 ended
outstanding shares of NINE, at the price of not lower than Baht 2.62 per share which is the average price that the Company acquired the NINE’s ordinary shares. Additionally, the total amount received from the
2017 to $92 in 3Q 2018, driven by tight PTA supply/demand situation, despite increased Paraxylene prices. Although IPA margins have weakened substantially, West Feedstock core EBITDA remained steady at